Tokyo Tape
Sign in

Eisai

4523.TPharmaceutical
Financials · Consolidated
ConsolidatedStandalone
Fiscal year ended2026-032025-032024-032023-032022-032021-03
Revenue¥825.4bn¥789.4bn¥741.8bn¥744.4bn¥756.2bn¥645.9bn
Operating income¥44.1bn¥54.4bn¥53.4bn¥40.0bn¥53.8bn¥51.5bn
Net income (owners)¥38.6bn¥46.4bn¥42.4bn¥55.4bn¥48.0bn¥41.9bn
Total assets¥1.45T¥1.39T¥1.39T¥1.26T¥1.24T¥1.09T
Net assets / equity¥925.1bn¥866.0bn¥899.0bn¥822.6bn¥771.5bn¥726.4bn
Operating cash flow¥61.3bn¥30.1bn¥56.0bn−¥1.8bn¥117.6bn¥73.1bn
EPS (basic)¥136.78¥163.76¥147.86¥193.31¥167.27¥146.34

From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.

Reports · 13
AllAnnual 5Half-year 2Quarterly 620262025202420232022
PeriodFormFiledFigures
2025-04-01 → 2026-03-31Annual2026-06-12204 figures · EDINET
2025-04-01 → 2025-09-30Half-year2025-11-1277 figures · EDINET
2024-04-01 → 2025-03-31Annual2025-06-13206 figures · EDINET
2024-04-01 → 2024-09-30Half-year2024-11-0877 figures · EDINET
2023-04-01 → 2024-03-31Annual2024-06-14212 figures · EDINET
2023-04-01 → 2023-12-31Quarterly Q32024-02-13104 figures · EDINET
2023-04-01 → 2023-09-30Quarterly Q22023-11-07104 figures · EDINET
2023-04-01 → 2023-06-30Quarterly Q12023-08-0982 figures · EDINET
2022-04-01 → 2023-03-31Annual2023-06-21212 figures · EDINET
2022-04-01 → 2022-12-31Quarterly Q32023-02-14106 figures · EDINET
2022-04-01 → 2022-09-30Quarterly Q22022-11-09106 figures · EDINET
2022-04-01 → 2022-06-30Quarterly Q12022-08-0582 figures · EDINET
2021-04-01 → 2022-03-31Annual2022-06-17212 figures · EDINET

21 more reports are still being processed.

Segments · FY ended 2026-03
SegmentExternal salesProfit
Americas¥300.4bn¥174.4bn
China¥130.7bn¥59.3bn
East Asia Global South¥68.8bn¥30.2bn
EMEA¥81.5bn¥30.4bn
Japan¥229.2bn¥73.0bn
Other segments¥14.6bn¥4.5bn
Total¥810.8bn¥367.3bn
Total¥825.4bn¥371.8bn

Segment names from EDINET member IDs; not mapped to a common taxonomy.